(Q48869626)

16 February 2018

title

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. (English)

1 reference

16 February 2018

0 references

0 references

Deibel MA

1

1 reference

16 February 2018

Ehmann WD

series ordinal

2

1 reference

16 February 2018

Markesbery WR

series ordinal

3

1 reference

16 February 2018

publication date

1 November 1996

1 reference

16 February 2018

Journal of the Neurological Sciences

published in

1 reference

16 February 2018

volume

143

1 reference

16 February 2018

page(s)

137-142

1 reference

16 February 2018

issue

1-2

1 reference

16 February 2018

A possible role of zinc in the pathology of dementia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Rapid induction of Alzheimer A beta amyloid formation by zinc.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Oxidative stress, glutamate, and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Ferritin and ceruloplasmin in oxidative damage: review and recent findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Applications of neutron activation analysis to the study of age-related neurological diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Ferritin: isolation of aluminum-ferritin complex from brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Editorial: The prevalence and malignancy of Alzheimer disease. A major killer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Diagnosis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Brain Cytochrome Oxidase in Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Ceruloplasmin inhibits carbonyl formation in endogenous cell proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Cortical cytochrome oxidase activity is reduced in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

A radical hypothesis for neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Trace elements in the human central nervous system studied with neutron activation analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Effects of ceruloplasmin on superoxide-dependent iron release from ferritin and lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Elemental imbalances in the olfactory pathway in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first-degree relatives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900203-1

10.1016/S0022-510X(96)00203-1

7 January 2021

Identifiers

DOI

1 reference

16 February 2018

PubMed ID

8981312

1 reference

16 February 2018